• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低收入国家卫生系统的治理安排:系统评价综述

Governance arrangements for health systems in low-income countries: an overview of systematic reviews.

作者信息

Herrera Cristian A, Lewin Simon, Paulsen Elizabeth, Ciapponi Agustín, Opiyo Newton, Pantoja Tomas, Rada Gabriel, Wiysonge Charles S, Bastías Gabriel, Garcia Marti Sebastian, Okwundu Charles I, Peñaloza Blanca, Oxman Andrew D

机构信息

Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Marcoleta 434, Santiago, Chile.

出版信息

Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011085. doi: 10.1002/14651858.CD011085.pub2.

DOI:10.1002/14651858.CD011085.pub2
PMID:28895125
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5618451/
Abstract

BACKGROUND

Governance arrangements include changes in rules or processes that determine authority and accountability for health policies, organisations, commercial products and health professionals, as well as the involvement of stakeholders in decision-making. Changes in governance arrangements can affect health and related goals in numerous ways, generally through changes in authority, accountability, openness, participation and coherence. A broad overview of the findings of systematic reviews can help policymakers, their technical support staff and other stakeholders to identify strategies for addressing problems and improving the governance of their health systems.

OBJECTIVES

To provide an overview of the available evidence from up-to-date systematic reviews about the effects of governance arrangements for health systems in low-income countries. Secondary objectives include identifying needs and priorities for future evaluations and systematic reviews on governance arrangements and informing refinements of the framework for governance arrangements outlined in the overview.

METHODS

We searched Health Systems Evidence in November 2010 and PDQ Evidence up to 17 December 2016 for systematic reviews. We did not apply any date, language or publication status limitations in the searches. We included well-conducted systematic reviews of studies that assessed the effects of governance arrangements on patient outcomes (health and health behaviours), the quality or utilisation of healthcare services, resource use (health expenditures, healthcare provider costs, out-of-pocket payments, cost-effectiveness), healthcare provider outcomes (such as sick leave), or social outcomes (such as poverty, employment) and that were published after April 2005. We excluded reviews with limitations that were important enough to compromise the reliability of the findings of the review. Two overview authors independently screened reviews, extracted data and assessed the certainty of evidence using GRADE. We prepared SUPPORT Summaries for eligible reviews, including key messages, 'Summary of findings' tables (using GRADE to assess the certainty of the evidence) and assessments of the relevance of findings to low-income countries.

MAIN RESULTS

We identified 7272 systematic reviews and included 21 of them in this overview (19 primary reviews and 2 supplementary reviews). We focus here on the results of the 19 primary reviews, one of which had important methodological limitations. The other 18 were reliable (with only minor limitations).We grouped the governance arrangements addressed in the reviews into five categories: authority and accountability for health policies (three reviews); authority and accountability for organisations (two reviews); authority and accountability for commercial products (three reviews); authority and accountability for health professionals (seven reviews); and stakeholder involvement (four reviews).Overall, we found desirable effects for the following interventions on at least one outcome, with moderate- or high-certainty evidence and no moderate- or high-certainty evidence of undesirable effects. Decision-making about what is covered by health insurance- Placing restrictions on the medicines reimbursed by health insurance systems probably decreases the use of and spending on these medicines (moderate-certainty evidence). Stakeholder participation in policy and organisational decisions- Participatory learning and action groups for women probably improve newborn survival (moderate-certainty evidence).- Consumer involvement in preparing patient information probably improves the quality of the information and patient knowledge (moderate-certainty evidence). Disclosing performance information to patients and the public- Disclosing performance data on hospital quality to the public probably encourages hospitals to implement quality improvement activities (moderate-certainty evidence).- Disclosing performance data on individual healthcare providers to the public probably leads people to select providers that have better quality ratings (moderate-certainty evidence).

AUTHORS' CONCLUSIONS: Investigators have evaluated a wide range of governance arrangements that are relevant for low-income countries using sound systematic review methods. These strategies have been targeted at different levels in health systems, and studies have assessed a range of outcomes. Moderate-certainty evidence shows desirable effects (with no undesirable effects) for some interventions. However, there are important gaps in the availability of systematic reviews and primary studies for the all of the main categories of governance arrangements.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6f/6483746/2e4509bde36b/nCD011085-AFig-FIG01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6f/6483746/2e4509bde36b/nCD011085-AFig-FIG01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea6f/6483746/2e4509bde36b/nCD011085-AFig-FIG01.jpg
摘要

背景

治理安排包括规则或流程的变化,这些变化决定了卫生政策、组织、商业产品和卫生专业人员的权力与问责,以及利益相关者在决策中的参与。治理安排的变化通常会通过权力、问责、开放性、参与度和连贯性的改变,以多种方式影响健康及相关目标。对系统评价结果进行全面概述,有助于政策制定者、其技术支持人员及其他利益相关者确定解决问题和改善卫生系统治理的策略。

目的

概述来自最新系统评价的现有证据,这些证据涉及低收入国家卫生系统治理安排的影响。次要目的包括确定未来关于治理安排的评价和系统评价的需求与优先事项,并为概述中所述治理安排框架的完善提供信息。

方法

我们于2010年11月检索了“卫生系统证据”,并截至2016年12月17日检索了“PDQ证据”以获取系统评价。检索时未应用任何日期、语言或出版状态限制。我们纳入了对评估治理安排对患者结局(健康和健康行为)、医疗服务质量或利用、资源使用(卫生支出、医疗服务提供者成本、自付费用、成本效益)、医疗服务提供者结局(如病假)或社会结局(如贫困、就业)影响的研究进行的高质量系统评价,且这些评价于2005年4月之后发表。我们排除了存在严重到足以损害评价结果可靠性的局限性的评价。两位概述作者独立筛选评价、提取数据并使用GRADE评估证据的确定性。我们为符合条件的评价编制了SUPPORT摘要,包括关键信息、“结果摘要”表(使用GRADE评估证据的确定性)以及对结果与低收入国家相关性的评估。

主要结果

我们识别出7272项系统评价,并在本概述中纳入了其中21项(19项主要评价和2项补充评价)。我们在此重点关注19项主要评价的结果,其中一项存在重要的方法学局限性。其他18项可靠(仅有轻微局限性)。我们将评价中涉及的治理安排分为五类:卫生政策的权力与问责(三项评价);组织的权力与问责(两项评价);商业产品的权力与问责(三项评价);卫生专业人员的权力与问责(七项评价);以及利益相关者参与(四项评价)。总体而言,我们发现以下干预措施对至少一项结局有预期效果,证据确定性为中等或高,且无中等或高确定性证据表明存在不良效果。医疗保险覆盖范围的决策——对医疗保险系统报销的药品进行限制可能会减少这些药品的使用和支出(中等确定性证据)。利益相关者参与政策和组织决策——妇女参与式学习和行动小组可能会提高新生儿存活率(中等确定性证据)。——消费者参与编写患者信息可能会提高信息质量和患者知识水平(中等确定性证据)。向患者和公众披露绩效信息——向公众披露医院质量绩效数据可能会鼓励医院开展质量改进活动(中等确定性证据)。——向公众披露个体医疗服务提供者的绩效数据可能会使人们选择质量评级更高的提供者(中等确定性证据)。

作者结论

研究人员已使用合理的系统评价方法评估了与低收入国家相关的广泛治理安排。这些策略针对卫生系统的不同层面,且研究评估了一系列结局。中等确定性证据表明某些干预措施有预期效果(无不良效果)。然而,在治理安排所有主要类别的系统评价和原始研究的可得性方面存在重要差距。

相似文献

1
Governance arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的治理安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011085. doi: 10.1002/14651858.CD011085.pub2.
2
Financial arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的财务安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD011084. doi: 10.1002/14651858.CD011084.pub2.
3
Delivery arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的交付安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD011083. doi: 10.1002/14651858.CD011083.pub2.
4
Implementation strategies for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的实施策略:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011086. doi: 10.1002/14651858.CD011086.pub2.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Stakeholders' perceptions and experiences of factors influencing the commissioning, delivery, and uptake of general health checks: a qualitative evidence synthesis.利益相关者对影响一般健康检查的委托、提供和接受因素的看法与体验:一项定性证据综合分析
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD014796. doi: 10.1002/14651858.CD014796.pub2.
7
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries.无条件现金转移以减少贫困和脆弱性:对中低收入国家卫生服务利用和健康结果的影响。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD011135. doi: 10.1002/14651858.CD011135.pub3.
10
Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.消费者和医疗服务提供者合作对卫生服务规划、提供和评估的影响。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013373. doi: 10.1002/14651858.CD013373.pub2.

引用本文的文献

1
Evidence synthesis of health policy and systems research in rehabilitation: a protocol for Cochrane overviews of systematic reviews on delivery, governance, financial arrangements, and implementation strategies.康复领域卫生政策与系统研究的证据综合:Cochrane系统评价概述的方案,涉及服务提供、治理、财务安排和实施策略
Eur J Phys Rehabil Med. 2025 Apr;61(2):335-350. doi: 10.23736/S1973-9087.24.08833-6. Epub 2025 Jan 27.
2
National and international programmatic perspective on facilitators and barriers for Sudan's health sector response on female genital mutilation (2016-2018): a qualitative study.国家和国际计划视角下的苏丹女性生殖器官切割卫生部门应对措施的促进因素和障碍(2016-2018 年):一项定性研究。
BMJ Open. 2023 Jun 14;13(6):e070138. doi: 10.1136/bmjopen-2022-070138.
3

本文引用的文献

1
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
2
Delivery arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的交付安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD011083. doi: 10.1002/14651858.CD011083.pub2.
3
Implementation strategies for health systems in low-income countries: an overview of systematic reviews.
Quality of care in the context of universal health coverage: a scoping review.全民健康覆盖背景下的医疗质量:范围综述。
Health Res Policy Syst. 2023 Mar 23;21(1):21. doi: 10.1186/s12961-022-00957-5.
4
Using and improving the PHISICC paper-based tools in the health facility laboratories: Examples of Human Centered Design taking systems thinking into practice, in Côte d'Ivoire and Nigeria.在医疗机构实验室中使用和改进基于纸张的 PHISICC 工具:以系统思维为实践指导的以人为本的设计示例,在科特迪瓦和尼日利亚。
Front Public Health. 2022 Sep 15;10:916397. doi: 10.3389/fpubh.2022.916397. eCollection 2022.
5
Barriers to increase surgical productivity in Sierra Leone: a qualitative study.提高塞拉利昂外科手术生产力的障碍:一项定性研究。
BMJ Open. 2021 Dec 21;11(12):e056784. doi: 10.1136/bmjopen-2021-056784.
6
Community health workers at the dawn of a new era: 3. Programme governance.新时代的社区卫生工作者:3. 项目治理。
Health Res Policy Syst. 2021 Oct 12;19(Suppl 3):129. doi: 10.1186/s12961-021-00749-3.
7
Global Surgery Indicators and Pediatric Hydrocephalus: A Multicenter Cross-Country Comparative Study Building the Case for Health System Strengthening.全球外科手术指标与小儿脑积水:一项多中心跨国比较研究,为加强卫生系统提供依据
Front Surg. 2021 Aug 26;8:704346. doi: 10.3389/fsurg.2021.704346. eCollection 2021.
8
Participation by conflict-affected and forcibly displaced communities in humanitarian healthcare responses: A systematic review.受冲突影响和被迫流离失所社区参与人道主义医疗应对:一项系统综述。
J Migr Health. 2020 Dec 9;1-2:100026. doi: 10.1016/j.jmh.2020.100026. eCollection 2020.
9
How does the effectiveness of strategies to improve healthcare provider practices in low-income and middle-income countries change after implementation? Secondary analysis of a systematic review.在实施后,改善中低收入国家医疗服务提供者实践的策略的效果如何变化?系统评价的二次分析。
BMJ Qual Saf. 2022 Feb;31(2):123-133. doi: 10.1136/bmjqs-2020-011717. Epub 2021 May 18.
10
Implementing a Social Accountability Approach for Maternal, Neonatal, and Child Health Service Performances in Ethiopia: A Pre-Post Study Design.在埃塞俄比亚实施母婴和儿童健康服务绩效的社会问责制方法:一项前后研究设计。
Glob Health Sci Pract. 2021 Mar 31;9(1):123-135. doi: 10.9745/GHSP-D-20-00114.
低收入国家卫生系统的实施策略:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011086. doi: 10.1002/14651858.CD011086.pub2.
4
Financial arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的财务安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD011084. doi: 10.1002/14651858.CD011084.pub2.
5
Interventions for increasing the proportion of health professionals practising in rural and other underserved areas.增加在农村及其他服务欠缺地区执业的卫生专业人员比例的干预措施。
Cochrane Database Syst Rev. 2015 Jun 30;2015(6):CD005314. doi: 10.1002/14651858.CD005314.pub3.
6
Rapid response systems: a systematic review and meta-analysis.快速反应系统:一项系统评价与荟萃分析
Crit Care. 2015 Jun 12;19(1):254. doi: 10.1186/s13054-015-0973-y.
7
Developing and refining the methods for a 'one-stop shop' for research evidence about health systems.开发并完善获取卫生系统研究证据的“一站式服务”方法。
Health Res Policy Syst. 2015 Feb 25;13:10. doi: 10.1186/1478-4505-13-10.
8
Interventions to combat or prevent drug counterfeiting: a systematic review.打击或预防药品假冒的干预措施:一项系统综述
BMJ Open. 2015 Mar 18;5(3):e006290. doi: 10.1136/bmjopen-2014-006290.
9
Strategies for expanding health insurance coverage in vulnerable populations.扩大弱势群体医疗保险覆盖范围的策略。
Cochrane Database Syst Rev. 2014 Nov 26;2014(11):CD008194. doi: 10.1002/14651858.CD008194.pub3.
10
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.药品政策:参考定价、其他定价及采购政策的影响
Cochrane Database Syst Rev. 2014 Oct 16;2014(10):CD005979. doi: 10.1002/14651858.CD005979.pub2.